China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
0.479
-0.051 (-9.64%)
At close: Nov 4, 2024, 4:00 PM
0.460
-0.019 (-3.95%)
Pre-market: Nov 5, 2024, 6:54 AM EST

China SXT Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Nov '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2016
Market Capitalization
213112916
Upgrade
Market Cap Growth
-67.93%-67.93%-73.96%-60.15%83.81%-89.90%
Upgrade
Enterprise Value
-7-7214199
Upgrade
Last Close Price
0.481.687.09140.00920.001120.20
Upgrade
PE Ratio
--0.47-0.32-1.02-9.64-1.35
Upgrade
PS Ratio
0.220.491.504.375.973.01
Upgrade
PB Ratio
0.080.070.200.691.791.65
Upgrade
P/FCF Ratio
-0.49-0.49-19.5655.27-20.2529.44
Upgrade
P/OCF Ratio
-0.49-0.49-36.6842.40-21.6816.62
Upgrade
EV/Sales Ratio
-3.87-3.870.795.373.931.77
Upgrade
EV/EBITDA Ratio
3.953.95-0.31-2.87-10.15-9.06
Upgrade
EV/EBIT Ratio
3.563.56-0.30-2.69-8.55-6.82
Upgrade
EV/FCF Ratio
3.853.85-10.2867.89-13.3317.33
Upgrade
Debt / Equity Ratio
0.270.270.610.650.760.72
Upgrade
Debt / FCF Ratio
-1.91-1.91-59.1752.20-8.6512.74
Upgrade
Asset Turnover
0.070.070.060.080.170.26
Upgrade
Inventory Turnover
1.981.981.881.101.602.07
Upgrade
Quick Ratio
1.511.511.311.141.001.26
Upgrade
Current Ratio
1.601.601.351.311.251.60
Upgrade
Return on Equity (ROE)
-21.65%-21.65%-38.15%-35.42%-21.67%-100.32%
Upgrade
Return on Assets (ROA)
-4.96%-4.96%-10.42%-9.53%-4.88%-4.28%
Upgrade
Return on Capital (ROIC)
-6.34%-6.34%-12.93%-11.73%-6.20%-5.58%
Upgrade
Earnings Yield
-186.13%-326.13%-200.33%-50.42%-9.63%-66.24%
Upgrade
FCF Yield
-116.24%-203.68%-5.11%1.81%-4.94%3.40%
Upgrade
Buyback Yield / Dilution
-224.91%-224.91%-541.90%-44.50%-132.79%-20.23%
Upgrade
Total Shareholder Return
-224.91%-224.91%-541.90%-44.50%-132.79%-20.23%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.